Dimed S.A. Distribuidora de Medicamentos (PNVL3.SA)
BRL 9.03
(-1.63%)
BRL 9.03
(-1.63%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 396.86 Million BRL | 2.86% |
| 2022 | 335.82 Million BRL | 19.39% |
| 2021 | 260.55 Million BRL | 42.81% |
| 2020 | 211.17 Million BRL | -7.87% |
| 2019 | 213.27 Million BRL | 61.75% |
| 2018 | 138.51 Million BRL | 18.32% |
| 2017 | 115.71 Million BRL | -1.76% |
| 2016 | 111.53 Million BRL | 14.54% |
| 2015 | 102.22 Million BRL | 3.21% |
| 2014 | 88.66 Million BRL | 12.57% |
| 2013 | 88.62 Million BRL | -3.65% |
| 2012 | 74.59 Million BRL | 23.15% |
| 2011 | 71.51 Million BRL | 7.94% |
| 2010 | 52.26 Million BRL | 27.66% |
| 2009 | 42.45 Million BRL | 263.42% |
| 2008 | 42.63 Million BRL | -39.05% |
| 2007 | 46.18 Million BRL | 14.83% |
| 2006 | 20.4 Million BRL | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 101.31 Million BRL | 2.98% |
| 2024 Q2 | 77.23 Million BRL | -22.91% |
| 2023 Q4 | 82.55 Million BRL | -21.72% |
| 2023 FY | - BRL | 2.86% |
| 2023 Q3 | 105.45 Million BRL | 7.17% |
| 2023 Q1 | 91.59 Million BRL | 12.46% |
| 2023 Q2 | 98.39 Million BRL | 7.43% |
| 2022 Q3 | 89.48 Million BRL | -2.56% |
| 2022 FY | - BRL | 19.39% |
| 2022 Q2 | 91.83 Million BRL | 24.96% |
| 2022 Q4 | 81.44 Million BRL | -8.98% |
| 2022 Q1 | 73.49 Million BRL | 2.06% |
| 2021 Q3 | 68.53 Million BRL | -4.0% |
| 2021 FY | - BRL | 42.81% |
| 2021 Q1 | 68.99 Million BRL | 25.66% |
| 2021 Q2 | 71.39 Million BRL | 3.48% |
| 2021 Q4 | 72.01 Million BRL | 5.07% |
| 2020 Q1 | 53.54 Million BRL | -4.21% |
| 2020 FY | - BRL | -7.87% |
| 2020 Q2 | 47.47 Million BRL | -11.34% |
| 2020 Q3 | 61.39 Million BRL | 29.33% |
| 2020 Q4 | 54.9 Million BRL | -10.57% |
| 2019 Q3 | 56.76 Million BRL | 6.01% |
| 2019 Q4 | 55.89 Million BRL | -1.53% |
| 2019 FY | - BRL | 61.75% |
| 2019 Q1 | 46.3 Million BRL | 25.24% |
| 2019 Q2 | 53.55 Million BRL | 15.65% |
| 2018 Q3 | 31.38 Million BRL | -2.13% |
| 2018 Q4 | 36.97 Million BRL | 17.82% |
| 2018 Q2 | 32.06 Million BRL | 26.92% |
| 2018 Q1 | 25.26 Million BRL | 15.69% |
| 2018 FY | - BRL | 18.32% |
| 2017 Q4 | 21.83 Million BRL | -2.86% |
| 2017 Q1 | 29.36 Million BRL | 11.72% |
| 2017 Q2 | 31.57 Million BRL | 7.53% |
| 2017 FY | - BRL | -1.76% |
| 2017 Q3 | 22.47 Million BRL | -28.8% |
| 2016 FY | - BRL | 14.54% |
| 2016 Q4 | 26.28 Million BRL | -6.57% |
| 2016 Q3 | 28.12 Million BRL | -19.1% |
| 2016 Q2 | 34.76 Million BRL | 27.64% |
| 2016 Q1 | 27.24 Million BRL | -0.32% |
| 2015 Q2 | 27.44 Million BRL | 60.0% |
| 2015 FY | - BRL | 3.21% |
| 2015 Q3 | 26.87 Million BRL | -2.05% |
| 2015 Q4 | 27.32 Million BRL | 1.67% |
| 2015 Q1 | 17.15 Million BRL | -52.34% |
| 2014 Q3 | 20.25 Million BRL | -18.62% |
| 2014 Q1 | 14.41 Million BRL | -0.37% |
| 2014 FY | - BRL | 12.57% |
| 2014 Q4 | 35.98 Million BRL | 77.69% |
| 2014 Q2 | 24.88 Million BRL | 72.58% |
| 2013 Q1 | 16.95 Million BRL | -43.85% |
| 2013 FY | - BRL | -3.65% |
| 2013 Q4 | 14.47 Million BRL | -48.28% |
| 2013 Q3 | 27.98 Million BRL | 14.86% |
| 2013 Q2 | 24.36 Million BRL | 43.72% |
| 2012 FY | - BRL | 23.15% |
| 2012 Q3 | 18.62 Million BRL | 0.0% |
| 2012 Q4 | 30.19 Million BRL | 62.06% |
| 2011 FY | - BRL | 7.94% |
| 2010 FY | - BRL | 27.66% |
| 2009 FY | - BRL | 263.42% |
| 2008 FY | - BRL | -39.05% |
| 2007 FY | - BRL | 14.83% |
| 2006 FY | - BRL | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|